Catalyst Pharmaceuticals, Inc.
Catalyst Pharmaceuticals, Inc. (CPRX) Stock Overview
Explore Catalyst Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
3.4B
P/E Ratio
15.57
EPS (TTM)
$1.68
ROE
0.24%
CPRX Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Catalyst Pharmaceuticals, Inc. (CPRX) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 67.38, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $28.40.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 15.57 and a market capitalization of 3.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.